Proteome Sciences Plc (PRM):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Proteome Sciences Plc (PRM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9768
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Proteome Sciences Plc (Proteome Sciences) is a life sciences company that delivers content for personalized medicine through biomarkers, reagents and services. Its proteomics services include drug development, biomarker discovery and provision of data insights. It maps the protein expressions and modifications that help define processes for improving research outcomes. The company detects and characterizes deferentially expressed proteins using its proprietary technologies in biological samples for prognostic, diagnostic and therapeutic applications. The company develops novel biomarkers for various disease areas such as central nervous system diseases including Alzheimer’s, Huntington’s, stroke and traumatic brain injury; oncology comprising lung, breast, colorectal and esophageal cancers; and cardiac diseases, for diagnostic and treatment applications. It has facilities in London and Frankfurt. Proteome Sciences is headquartered in London, England, the UK.

Proteome Sciences Plc (PRM) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Proteome Sciences Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Proteome Sciences Plc, Medical Devices Deals, 2012 to YTD 2018 9
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Proteome Sciences Enters Into Co-Development Agreement With Thermo Fisher 11
Proteome Sciences Enters Into Co-Development Agreement With CHDI Foundation 13
Equity Offering 14
Proteome Sciences Raises USD1.3 Million in Second and Final Tranche of Private Placement of Shares 14
Proteome Sciences Raises USD2.8 Million in First Tranche of Private Placement of Shares 15
Proteome Sciences to Raise USD4 Million in Private Placement of Shares 16
Proteome Sciences Announces Private Placement Of Shares For US$8.3 Million 17
Proteome Sciences Completes Private Placement Of Common Stock For US$2.4 Million 18
Proteome Sciences Plc – Key Competitors 19
Proteome Sciences Plc – Key Employees 20
Proteome Sciences Plc – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 23
Financial Announcements 23
Jul 24, 2018: Proteome Sciences: Interim results for the six months ended 30 June 2018 23
Apr 24, 2018: Proteome Sciences: Preliminary results for the year ended 31 December 2017 26
Jul 25, 2017: Proteome Sciences: Interim Results for the Six Months Ended 30 June 2017 31
Mar 28, 2017: Proteome Sciences Announces Preliminary results for the year ended 31 December 2016 Notice of AGM 32
Corporate Communications 43
Apr 24, 2018: Proteome Sciences Appoints Richard Dennis As Board Director 43
Aug 01, 2017: Proteome Sciences: Directorate changes 44
Apr 03, 2017: Proteome Sciences Announces Appointment of Richard Dennis as Chief Commercial Officer 45
Legal and Regulatory 46
Oct 18, 2017: Proteome Sciences: GCLP Accreditation and Trading Update 46
Other Significant Developments 47
Nov 06, 2018: Proteome Sciences: Trading update confirmation of preferred provider status 47
Jun 12, 2017: Proteome Sciences: New Registered Address 48
Appendix 49
Methodology 49
About GlobalData 49
Contact Us 49
Disclaimer 49

List of Tables
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Proteome Sciences Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Proteome Sciences Plc, Deals By Therapy Area, 2012 to YTD 2018 8
Proteome Sciences Plc, Medical Devices Deals, 2012 to YTD 2018 9
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Proteome Sciences Enters Into Co-Development Agreement With Thermo Fisher 11
Proteome Sciences Enters Into Co-Development Agreement With CHDI Foundation 13
Proteome Sciences Raises USD1.3 Million in Second and Final Tranche of Private Placement of Shares 14
Proteome Sciences Raises USD2.8 Million in First Tranche of Private Placement of Shares 15
Proteome Sciences to Raise USD4 Million in Private Placement of Shares 16
Proteome Sciences Announces Private Placement Of Shares For US$8.3 Million 17
Proteome Sciences Completes Private Placement Of Common Stock For US$2.4 Million 18
Proteome Sciences Plc, Key Competitors 19
Proteome Sciences Plc, Key Employees 20
Proteome Sciences Plc, Other Locations 21
Proteome Sciences Plc, Subsidiaries 21

List of Figures
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Proteome Sciences Plc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Proteome Sciences Plc (PRM):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Minnesota Municipal Power Agency:企業の戦略的SWOT分析
    Minnesota Municipal Power Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • CSR Ltd:企業の戦略・SWOT・財務情報
    CSR Ltd - Strategy, SWOT and Corporate Finance Report Summary CSR Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Intrexon Corp (XON):企業の財務・戦略的SWOT分析
    Summary Intrexon Corp (Intrexon), formerly Genomatix Corp is a synthetic biology service provider. The company operates through its divisions and units such as cell engineering, data sciences and computational biology, information technology (IT), actobiotics, molecular engineering, agricultural bio …
  • Brenntag Canada Inc:企業の戦略的SWOT分析
    Brenntag Canada Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • I.Ceram SA (ALICR):医療機器:M&Aディール及び事業提携情報
    Summary I.Ceram SA (I.Ceram) is a medical equipment and device company that designs, manufactures, and markets joint implants for neurosurgery and other surgical procedures. The company’s products include bone fillers, alumina bio-ceramic implants, trepan caps, cervical plates and blocks for cervica …
  • Memphasys Ltd (MEM):医療機器:M&Aディール及び事業提携情報
    Summary Memphasys Ltd (Memphasys), formerly Nusep Holdings Ltd, is a bio-separations company that develops and commercializes membrane technology solutions. The company develops felix, a non-DNA damaging lab instrument for sperm separation that separates sperm from semen sample using electrophoresis …
  • MeVis Medical Solutions AG (M3V):企業の財務・戦略的SWOT分析
    MeVis Medical Solutions AG (M3V) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Aridis Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Aridis Pharmaceuticals Inc (Aridis) is a biopharmaceutical companythat focusses on development of novel, differentiated therapies for infectious diseases. The company’s pipeline product uses disruptive platform technology to discover potent human monoclonal antibodies from patients.Its propr …
  • Landmark Graphics Corp:企業の戦略的SWOT分析
    Landmark Graphics Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Chorus Clean Energy AG (CU1):電力:M&Aディール及び事業提携情報
    Summary Chorus Clean Energy AG (Chorus Clean) is a renewable energy company that offers solar energy and wind energy development services. The company's services include technical and commercial management, asset sourcing, operational management, due diligence, documentation and reporting, commercia …
  • Houston American Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    Houston American Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary Houston American Energy Corp (Houston American Energy) is an oil and gas company that provides exploration and development services. The company concentrates on development, exploration, …
  • Sv. Sv. Konstantin I Elena Holding Ad:企業の戦略・SWOT・財務分析
    Sv. Sv. Konstantin I Elena Holding Ad - Strategy, SWOT and Corporate Finance Report Summary Sv. Sv. Konstantin I Elena Holding Ad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Abu Dhabi National Energy Co (TAQA):企業の財務・戦略的SWOT分析
    Abu Dhabi National Energy Co (TAQA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Grupo Nacional Provincial, S.A.B.:企業の戦略・SWOT・財務分析
    Grupo Nacional Provincial, S.A.B. - Strategy, SWOT and Corporate Finance Report Summary Grupo Nacional Provincial, S.A.B. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Titan Petrochemicals Group Ltd (1192):石油・ガス:M&Aディール及び事業提携情報
    Summary Titan Petrochemicals Group Limited (Titan) is an investment holding company that carries out midstream energy and shipbuilding operations. It provides oil storage, transit, and blending services. The company transports oil and petrochemical products; and supplies oil products. Titan also car …
  • China Southern Airlines Company Limited:企業の戦略・SWOT・財務情報
    China Southern Airlines Company Limited - Strategy, SWOT and Corporate Finance Report Summary China Southern Airlines Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Huons Global Co Ltd (084110):企業の財務・戦略的SWOT分析
    Huons Global Co Ltd (084110) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Grupo Televisa, S.A.B. (TLEVISACPO):企業の財務・戦略的SWOT分析
    Grupo Televisa, S.A.B. (TLEVISACPO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • ICON Plc (ICLR):企業の財務・戦略的SWOT分析
    ICON Plc (ICLR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • BTG Plc (BTG):製薬・医療:M&Aディール及び事業提携情報
    Summary BTG plc (BTG) develops, manufactures and sells medicines for acute care, cancer and vascular diseases. The company develops specialty drugs including antidotes for snake envenomation and toxicity related to medicines used for heart conditions and cancer; interventional vascular products for …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆